Replies to post #98837 on Biotech Values

[DewDiligence]

MON’s CEO and CEO bought $2M and $1.5M of stock this week on the open market at about $52/sh:

http://sec.gov/Archives/edgar/data/1083211/000111078310000041/xslF345X03/edgar.xml
http://sec.gov/Archives/edgar/data/1110783/000111078310000042/xslF345X03/edgar.xml

This is presumably part of the reason for the recent pop in MON’s share price, which is +22% this month.

After the recent purchases, Hugh Grant (CEO) and Carl Casale (CFO) own approximately $32M and $6M worth of stock, respectively.